Endocrinology, Vol 137, 663-676, Copyright © 1996 by Endocrine Society

ARTICLES

Effects of phenobarbital, dexamethasone, and 3-methylcholanthrene administration on the metabolism of 17 beta-estradiol by liver microsomes from female rats

LA Suchar, RL Chang, PE Thomas, RT Rosen, J Lech and AH Conney
Department of Chemical Biology and Pharmacognosy, College of Pharmacy, Rutgers, State University of New Jersey, Piscataway 08855, USA.

Female rats were treated with phenobarbital, dexamethasone, 3- methylcholanthrene, clofibrate, or isoniazid to induce different hepatic cytochromes P-450. The profile of hydroxylated metabolites of estradiol (E2) formed by liver microsomes was then determined using a new HPLC method for the separation of hydroxylated estrogen metabolites. Inhibition of liver microsomal E2 metabolism by monoclonal antibodies raised against specific cytochrome P-450 isozymes was also evaluated. Treatment of immature or adult female rats with phenobarbital caused a 3-fold increase in the 2-hydroxylation of E2 and a more than 5-fold increase in liver microsomal hydroxylation of E2 at the 4-, 6 alpha, 6 beta-, and 14 alpha-positions. Monoclonal antibody directed toward CYP2B1/2B2 completely inhibited the 6 alpha- and 6 beta- hydroxylation of E2 and partially inhibited the 2-hydroxylation of E2 by liver microsomes from phenobarbital-treated adult female rats. Antibodies directed toward CYP3A1/3A2 completely inhibited the 4- and 14 alpha-hydroxylation of E2 by these liver microsomes. Treatment of immature or adult female rats with dexamethasone resulted in a 2- to 3- fold increase in the microsomal 2-hydroxylation of E2 and a several- fold increase in the hydroxylation of E2 at the 4-, 6 beta-, 7 alpha-, and 14 alpha-positions. A substantial increase in the formation of two unidentified nonpolar metabolite peaks (UK1 and UK2) was also observed. A monoclonal antibody directed against CYP3A1/3A2 markedly inhibited the 2-, 4-, and 14 alpha-hydroxylation of E2 by liver microsomes from adult female rats treated with dexamethasone. Antibody directed against CYP2B1/2B2 inhibited only the 6 beta-hydroxylation of E2 by these microsomes. Treatment of immature or adult female rats with 3- methylcholanthrene resulted in a several-fold increase in the metabolism of E2 to 7 alpha-hydroxyestradiol (7 alpha-OH E2) and 15 alpha-OH E2, but there was a substantial decrease in the formation of 16 alpha-OH E2. Treatment with 3-methylcholanthrene caused a small increase in 2-hydroxylation (< or = 50%) in liver microsomes from immature or adult female rats, whereas a substantial increase in 6 alpha-hydroxylation was seen in liver microsomes from adult female rats. A monoclonal antibody directed toward CYP1A1 partially inhibited the 6 alpha-hydroxylation of E2 and the formation of the 7 alpha-OH E2/15 alpha-OH E2 peak by microsomes from adult female rats treated with 3-methylcholanthrene, but the 2-hydroxylation of E2 was not inhibited. Treatment of adult female rats with clofibrate increased the 2- and 4-hydroxylation of E2 by about 2-fold and by more than 6-fold, respectively. Isoniazid treatment had little or no effect on the metabolism of E2. The data demonstrate that prototype inducers of cytochrome P-450 can substantially alter the profile of hepatic E2 metabolism in female rats. Our results suggest that inducers of environmental relevance may also have an impact on E2 metabolism and homeostasis in humans.

This article has been cited by other articles:

				S. Mesia-Vela, R. I. Sanchez, K. R. Reuhl, A. H. Conney, and F. C. Kauffman Phenobarbital Treatment Inhibits the Formation of Estradiol-Dependent Mammary Tumors in the August-Copenhagen Irish Rat J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 590 - 597. [Abstract] [Full Text] [PDF]

				R. K. Dubey, E. K. Jackson, D. G. Gillespie, M. Rosselli, F. Barchiesi, A. Krust, H. Keller, L. C. Zacharia, and B. Imthurn Cytochromes 1A1/1B1- and Catechol-O-Methyltransferase-Derived Metabolites Mediate Estradiol-Induced Antimitogenesis in Human Cardiac Fibroblast J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 247 - 255. [Abstract] [Full Text] [PDF]

				M. Yoshida, S. Katashima, J. Ando, T. Tanaka, F. Uematsu, D. Nakae, and A. Maekawa Dietary indole-3-carbinol promotes endometrial adenocarcinoma development in rats initiated with N-ethyl-N'-nitro-N-nitrosoguanidine, with induction of cytochrome P450s in the liver and consequent modulation of estrogen metabolism Carcinogenesis, November 1, 2004; 25(11): 2257 - 2264. [Abstract] [Full Text] [PDF]

				V K Turan, R I Sanchez, J J Li, S A Li, K R Reuhl, P E Thomas, A H Conney, M A Gallo, F C Kauffman, and S Mesia-Vela The effects of steroidal estrogens in ACI rat mammary carcinogenesis: 17{beta}-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16{alpha}-hydroxyestradiol, and 4-hydroxyestrone J. Endocrinol., October 1, 2004; 183(1): 91 - 99. [Abstract] [Full Text] [PDF]

				A. J. Lee and B. T. Zhu NADPH-DEPENDENT FORMATION OF POLAR AND NONPOLAR ESTROGEN METABOLITES FOLLOWING INCUBATIONS OF 17{beta}-ESTRADIOL WITH HUMAN LIVER MICROSOMES Drug Metab. Dispos., August 1, 2004; 32(8): 876 - 883. [Abstract] [Full Text] [PDF]

				A. H. Conney Enzyme Induction and Dietary Chemicals as Approaches to Cancer Chemoprevention: The Seventh DeWitt S. Goodman Lecture Cancer Res., November 1, 2003; 63(21): 7005 - 7031. [Abstract] [Full Text] [PDF]

				F. Laden, N. Ishibe, S. E. Hankinson, M. S. Wolff, D. M. Gertig, D. J. Hunter, and K. T. Kelsey Polychlorinated Biphenyls, Cytochrome P450 1A1, and Breast Cancer Risk in the Nurses' Health Study Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1560 - 1565. [Abstract] [Full Text] [PDF]

				S. Mesia-Vela, R. I. Sanchez, J. J. Li, S. A. Li, A. H. Conney, and F. C. Kauffman Catechol estrogen formation in liver microsomes from female ACI and Sprague-Dawley rats: comparison of 2- and 4-hydroxylation revisited Carcinogenesis, August 1, 2002; 23(8): 1369 - 1372. [Abstract] [Full Text] [PDF]

				A. J. Lee, L. H. Mills, J. W. Kosh, A. H. Conney, and B. T. Zhu NADPH-Dependent Metabolism of Estrone by Human Liver Microsomes J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 838 - 849. [Abstract] [Full Text] [PDF]

				A. J. Lee, J. W. Kosh, A. H. Conney, and B. T. Zhu Characterization of the NADPH-Dependent Metabolism of 17beta -Estradiol to Multiple Metabolites by Human Liver Microsomes and Selectively Expressed Human Cytochrome P450 3A4 and 3A5 J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 420 - 432. [Abstract] [Full Text] [PDF]

				V. K. Turan, V. M. Mishin, and P. E. Thomas Clotrimazole is a Selective and Potent Inhibitor of Rat Cytochrome P450 3A Subfamily-Related Testosterone Metabolism Drug Metab. Dispos., June 1, 2001; 29(6): 837 - 842. [Abstract] [Full Text]

				A. M. Wilson and G. A. Reed Predominant 4-hydroxylation of estradiol by constitutive cytochrome P450s in the female ACI rat liver Carcinogenesis, February 1, 2001; 22(2): 257 - 263. [Abstract] [Full Text] [PDF]

				S. Xu, B. T. Zhu, and A. H. Conney Stimulatory Effect of Clofibrate and Gemfibrozil Administration on the Formation of Fatty Acid Esters of Estradiol by Rat Liver Microsomes J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 188 - 197. [Abstract] [Full Text]

				K. B. Moysich, P. G. Shields, J. L. Freudenheim, E. F. Schisterman, J. E. Vena, P. Kostyniak, H. Greizerstein, J. R. Marshall, S. Graham, and C. B. Ambrosone Polychlorinated Biphenyls, Cytochrome P4501A1 Polymorphism, and Postmenopausal Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., January 1, 1999; 8(1): 41 - 44. [Abstract] [Full Text]

				D. Liu and K. A. Bachmann An Investigation of the Relationship Between Estrogen, Estrogen Metabolites and Blood Cholesterol Levels in Ovariectomized Rats J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 561 - 568. [Abstract] [Full Text]